A two-antibody mismatch repair protein immunohistochemistry screening approach for colorectal carcinomas, skin sebaceous tumors, and gynecologic tract carcinomas.
about
Practical issues related to uterine pathology: staging, frozen section, artifacts, and Lynch syndromeHereditary Syndromes Manifesting as Endometrial Carcinoma: How Can Pathological Features Aid Risk Assessment?Genetic testing strategies in newly diagnosed endometrial cancer patients aimed at reducing morbidity or mortality from lynch syndrome in the index case or her relativesLynch syndrome-related small intestinal adenocarcinomas.Mismatch repair deficiency screening in colorectal carcinoma by a four-antibody immunohistochemical panel in Pakistani population and its correlation with histopathological parametersBRAFV600E immunohistochemistry facilitates universal screening of colorectal cancers for Lynch syndromeLynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer.Immunohistochemistry and microsatellite instability analysis in molecular subtyping of colorectal carcinoma based on mismatch repair competency.Prevalence of Lynch syndrome among patients with newly diagnosed endometrial cancers.Germline PMS2 mutation screened by mismatch repair protein immunohistochemistry of colorectal cancer in Japan.Hereditary gynaecological malignancies: advances in screening and treatment.The molecular genetics of eyelid tumors: recent advances and future directions.Lynch syndrome-associated neoplasms: a discussion on histopathology and immunohistochemistry.Discordant Mismatch Repair Protein Immunoreactivity in Lynch Syndrome-Associated Neoplasms: A Recommendation for Screening Synchronous/Metachronous Neoplasms.Review of the current medical literature and assessment of current utilization patterns regarding mismatch repair protein immunohistochemistry in cutaneous Muir-Torre syndrome-associated neoplasms.Practical guidance for mismatch repair-deficiency testing in endometrial cancer.
P2860
Q28080146-48BB644A-F5CB-4000-8CF8-26E651540C90Q28085485-A2B7ED65-DC57-4B28-A319-1A2800A9A80BQ31139897-255182C3-36C6-49D1-A3CF-3C9528886EF7Q33591577-0F4B2C8B-2A48-443C-9032-D7DA811D5C49Q33837506-717DD16F-2867-42A5-B5DD-52E70DB4DC06Q34782265-5E21EC0B-F95F-47B2-9359-FE7DCFE63D64Q35181103-FE2B903F-CFAC-4963-9896-0B94939E1E4DQ36492931-CBDCCF3A-1C07-4A91-9DDB-03C72D9689F8Q37288374-FF4F870D-42F9-4EB4-9087-B0A56DD2DDE3Q37462507-B7519EDC-E78B-45FF-83A8-42D4CEF50F9DQ38067433-717B1AEF-A40D-4998-83DD-F3ED0FE9AEC3Q38070357-5BB4ED13-A037-439A-BB32-FCE2400CA50AQ38084166-6C33554A-CCE8-4BA8-9E9B-3A6FF57B7B42Q47756509-F526633C-4587-4F45-993F-E50D0510CE6CQ48021660-8F7B2B8B-0EB5-4458-94B8-9ABCC5DDE5EAQ48478518-4B0A108D-05A5-48AA-BA51-049CC6322379
P2860
A two-antibody mismatch repair protein immunohistochemistry screening approach for colorectal carcinomas, skin sebaceous tumors, and gynecologic tract carcinomas.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A two-antibody mismatch repair ...... gynecologic tract carcinomas.
@en
A two-antibody mismatch repair ...... gynecologic tract carcinomas.
@nl
type
label
A two-antibody mismatch repair ...... gynecologic tract carcinomas.
@en
A two-antibody mismatch repair ...... gynecologic tract carcinomas.
@nl
prefLabel
A two-antibody mismatch repair ...... gynecologic tract carcinomas.
@en
A two-antibody mismatch repair ...... gynecologic tract carcinomas.
@nl
P2093
P2860
P1433
P1476
A two-antibody mismatch repair ...... gynecologic tract carcinomas.
@en
P2093
Amirkaveh Mojtahed
Iris Schrijver
Reetesh K Pai
Teri A Longacre
P2860
P2888
P304
P356
10.1038/MODPATHOL.2011.55
P50
P577
2011-04-15T00:00:00Z